Insights : sector - Osborne Clarke

Life Sciences and Healthcare

Learn more about this sector

Article list

Life Sciences and Healthcare

Standardisation for Clinical Trial Agreements: Germany’s New Standard Contractual Clauses

To bolster Germany’s attractiveness as a location for medical research, the Federal Government published standard contractual clauses (“SCC”) for clinical...

18/12/2025

Read time 4m

Life Sciences and Healthcare

European Parliament and Council provisional deal on new genomic techniques brings relaxation of gene editing a step closer

Two-tier categorisation of NGT plants endorsed alongside a patent ban rowback but patent transparency measures agreed

16/12/2025

Read time 5m

Life Sciences and Healthcare

EU's new bioeconomy strategy intends to harness sustainable innovation in life sciences and healthcare

Strategy aims to take advantage of 'biotechnology revolution', boost innovation and deliver sustainable solutions – what does this mean for...

15/12/2025

Read time 6m

Life Sciences and Healthcare

The US BIOSECURE Act: is your supply chain at risk?

The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal...

10/12/2025

Read time 6m

Life Sciences and Healthcare

EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026

First modules declared functional under phased approach, with vigilance and clinical studies still to follow

09/12/2025

Read time 5m

Life Sciences and Healthcare

Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal

Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector

08/12/2025

Read time 6m

Life Sciences and Healthcare

Autumn Budget 2025: what does recent government policy mean for UK life sciences and healthcare?

Targeted R&D support and faster regulatory pathways will be boosted by landmark UK-US pharmaceuticals deal

02/12/2025

Read time 7m

Regulatory Outlook

Products | UK Regulatory Outlook November 2025

General and Digital: European Commission consults on product safety and market surveillance | Council of the EU adopts 'one substance...

26/11/2025

Read time 9m

Life Sciences and Healthcare

Framework to fallout: Care Quality Commission launches single assessment framework review in England

Reforms could revert to a regime that social and health care providers were familiar with prior to changes in 2024

24/11/2025

Read time 5m

Life Sciences and Healthcare

Implications of the German GEMA ./. OpenAI judgment on the Life Sciences and Healthcare Sector

The District Court of Munich I has issued a landmark ruling on copyright infringement involving AI (11 November 2025, case...

24/11/2025

Read time 5m

Life Sciences and Healthcare

UK's biotech sector builds global life sciences status

TechBio conference showcases UK world-class research and biotech innovation

21/11/2025

Read time 4m

Intellectual property

Munich court grants Germany's first pan-EU cross-border patent injunction post-BSH v Electrolux

Munich Regional Court relied on BSH v Electrolux to injunct Formycon's aflibercept formulation in 22 countries based on doctrine of...

18/11/2025

Read time 8m

Life Sciences and Healthcare

European Medicines Agency encourages regulatory integration of patient experience data

Digital health gains ground in new EU paper discussing real-world evidence in pharma development

03/11/2025

Read time 6m

Health and safety regulation

Beauty and the health claims 'beast': a legal face lift for beauty marketing in Germany

On 9 October 2025 the German Federal Court of Justice (“BGH”) delivered a highly relevant judgment (I ZR 135/24 –...

24/10/2025

Read time 5m

Life Sciences and Healthcare

New regulatory framework established for the medicinal use of cannabis in Spain

The decree aims to balance therapeutic access to cannabis with guarantees of quality, safety and health control

24/10/2025

Read time 3m

View all insights

Life Sciences and Healthcare

Standardisation for Clinical Trial Agreements: Germany’s New Standard Contractual Clauses

To bolster Germany’s attractiveness as a location for medical research, the Federal Government published standard contractual clauses (“SCC”) for clinical...

18/12/2025

Read time 4m

Life Sciences and Healthcare

European Parliament and Council provisional deal on new genomic techniques brings relaxation of gene editing a step closer

Two-tier categorisation of NGT plants endorsed alongside a patent ban rowback but patent transparency measures agreed

16/12/2025

Read time 5m

Life Sciences and Healthcare

EU's new bioeconomy strategy intends to harness sustainable innovation in life sciences and healthcare

Strategy aims to take advantage of 'biotechnology revolution', boost innovation and deliver sustainable solutions – what does this mean for...

15/12/2025

Read time 6m

Life Sciences and Healthcare

The US BIOSECURE Act: is your supply chain at risk?

The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal...

10/12/2025

Read time 6m

Life Sciences and Healthcare

EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026

First modules declared functional under phased approach, with vigilance and clinical studies still to follow

09/12/2025

Read time 5m

Life Sciences and Healthcare

Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal

Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector

08/12/2025

Read time 6m

Life Sciences and Healthcare

Autumn Budget 2025: what does recent government policy mean for UK life sciences and healthcare?

Targeted R&D support and faster regulatory pathways will be boosted by landmark UK-US pharmaceuticals deal

02/12/2025

Read time 7m

Regulatory Outlook

Products | UK Regulatory Outlook November 2025

General and Digital: European Commission consults on product safety and market surveillance | Council of the EU adopts 'one substance...

26/11/2025

Read time 9m

Life Sciences and Healthcare

Framework to fallout: Care Quality Commission launches single assessment framework review in England

Reforms could revert to a regime that social and health care providers were familiar with prior to changes in 2024

24/11/2025

Read time 5m

Life Sciences and Healthcare

Implications of the German GEMA ./. OpenAI judgment on the Life Sciences and Healthcare Sector

The District Court of Munich I has issued a landmark ruling on copyright infringement involving AI (11 November 2025, case...

24/11/2025

Read time 5m

Life Sciences and Healthcare

UK's biotech sector builds global life sciences status

TechBio conference showcases UK world-class research and biotech innovation

21/11/2025

Read time 4m

Intellectual property

Munich court grants Germany's first pan-EU cross-border patent injunction post-BSH v Electrolux

Munich Regional Court relied on BSH v Electrolux to injunct Formycon's aflibercept formulation in 22 countries based on doctrine of...

18/11/2025

Read time 8m

Life Sciences and Healthcare

European Medicines Agency encourages regulatory integration of patient experience data

Digital health gains ground in new EU paper discussing real-world evidence in pharma development

03/11/2025

Read time 6m

Health and safety regulation

Beauty and the health claims 'beast': a legal face lift for beauty marketing in Germany

On 9 October 2025 the German Federal Court of Justice (“BGH”) delivered a highly relevant judgment (I ZR 135/24 –...

24/10/2025

Read time 5m

Life Sciences and Healthcare

New regulatory framework established for the medicinal use of cannabis in Spain

The decree aims to balance therapeutic access to cannabis with guarantees of quality, safety and health control

24/10/2025

Read time 3m

View all insights

Will James

Partner, International Life Sciences and Healthcare Sector Co-Leader

+44 207 105 7774 Email Will Full bio

Dr. Andrea Schmoll

Partner, International Life Sciences and Healthcare Sector Co-Leader

+49 221 5108 4408 Email Andrea Full bio

Thomas Devred

Partner, Head of Life Sciences and Healthcare - Paris

+ 33 1 84 82 41 06 Email Thomas Full bio

Silvia Steiner

Partner

+34 93 419 18 18 Email Silvia Full bio

Maria Grazia Medici

Partner, Head of Life Sciences & Healthcare

+39 06 3269 5015 Email Maria Grazia Full bio

Herke van Hulst

Partner, Lawyer

+31 207 02 86 72 Email Herke Full bio

Catherine Wolfenden

Partner, Disputes & Risk Practice Group Head

+44 117 917 3600 Email Catherine Full bio

Marcus Vass

Partner, Head of Digital Health

UK +44 2071 057 634 Email Marcus Full bio

Rafael García del Poyo

Partner

+34 91 576 44 76 Email Rafael Full bio

Peter Rudd-Clarke

Partner

+44 207 105 7315 Email Peter Full bio

Tim Harris

Partner

+44 207 105 7144 Email Tim Full bio

Giulia Verusio

Senior Associate

+39 06 3269 5008 Email Giulia Full bio

J. Carlos Suárez

Counsel

+39 02 5413 1772 Email J. Carlos Full bio

David Haex

Co-Managing Partner

+32 2 515 9322 Email David Full bio

Xavier Pican

Partner, IP/ IT

+33 1 84 82 45 88 Email Xavier Full bio

Julia Kaufmann, LL.M.

Partner

+49 89 5434 8068 Email Julia Full bio

Dr Flemming Moos

Partner, Specialist lawyer for IT law

+49 40 55436 4054 Email Flemming Full bio

Dr Tim Reinhard

Partner, Head of Intellectual Property Germany, Wirtschaftsmediator (MuCDR)

+49 89 5434 8024 Email Tim Full bio

Dr Martin Sundermann

Partner, Wirtschaftsmediator (MuCDR)

+49 89 5434 8026 Email Martin Full bio

Steve Wilson

Managing Partner

+1 917 545 3672 Email Steve Full bio

Jordi Casas

Co-Managing Partner

+34 93 419 18 18 Email Jordi Full bio

View all

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Insights

Life Sciences and Healthcare

Article list

Connect with one of our experts

Sign up for our newsletter

Legal Notice